Extension of the Calvert formula to patients with severe renal insufficiency-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Extension of the Calvert formula to patients with severe renal insufficiency

Published:2015-05-10 Issue:1 Volume:76 Page:53-59
ISSN:0344-5704
Container-title:Cancer Chemotherapy and Pharmacology
language:en
Short-container-title:Cancer Chemother Pharmacol

Author:

Oguri Tomoyo,Shimokata Tomoya,Ito Isao,Yasuda Yoshinari,Sassa Naoto,Nishiyama Masami,Hamada Akinobu,Hasegawa Yoshinori,Ando Yuichi

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s00280-015-2769-9.pdf

Reference22 articles.

1. Maisonneuve P, Agodoa L, Gellert R, Stewart JH, Buccianti G, Lowenfels AB et al (1999) Cancer in patients on dialysis for end-stage renal disease: an international collaborative study. Lancet 354:93–99

2. Calvert AH, Newell DR, Gumbrell LA, O’Reilly S, Burnell M, Boxall FE et al (1989) Carboplatin dosage: prospective evaluation of a simple formula based on renal function. J Clin Oncol 7:1748–1756

3. Ando Y, Shimokata T, Yasuda Y, Hasegawa Y (2014) Carboplatin dosing for adult Japanese patients. Nagoya J Med Sci 76:1–9

4. Oguri T, Shimokata T, Inada M, Ito I, Ando Y, Sasaki Y et al (2010) Pharmacokinetic analysis of carboplatin in patients with cancer who are undergoing hemodialysis. Cancer Chemother Pharmacol 66:813–817

5. Chatelut E, Rostaing L, Gualano V, Vissac T, De Forni M, Ton-That H et al (1994) Pharmacokinetics of carboplatin in a patient suffering from advanced ovarian carcinoma with hemodialysis-dependent renal insufficiency. Nephron 66:157–161

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Durvalumab plus carboplatin-etoposide treatment in a patient with small-cell lung cancer on hemodialysis: a case report and literature review;International Cancer Conference Journal;2023-12-21

2. Clinical questions and good practice statements of clinical practice guidelines for management of kidney injury during anticancer drug therapy 2022;Clinical and Experimental Nephrology;2023-10-25

3. Treatment of advanced ovarian cancer with carboplatin and paclitaxel in a patient undergoing hemodialysis: Case report and literature review;Hemodialysis International;2022-05-18

4. Is area under the curve the best parameter for carboplatin induced emetic risk stratification?;NAGOYA J MED SCI;2021

5. Platinum drugs in the Australian cancer chemotherapy healthcare setting: Is it worthwhile for chemists to continue to develop platinums?;Inorganica Chimica Acta;2019-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3